bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2021,
Volume and Issue:
unknown
Published: Nov. 2, 2021
Abstract
Human
papillomaviruses
(HPV)
are
causative
agents
in
ano-genital
and
oral
cancers;
HPV16
is
the
most
prevalent
type
detected
human
cancers.
The
E6
protein
targets
p53
for
proteasomal
degradation
to
facilitate
proliferation
of
infected
cell.
However,
immortalized
cells
predominantly
spliced
(E6*)
unable
degrade
p53.
Here
we
demonstrate
that
foreskin
keratinocytes
by
(HFK+HPV16),
positive
oropharyngeal
cancers,
retain
significant
expression
In
addition,
levels
can
be
increased
HPV16+
head
neck
cancer
cell
lines
following
treatment
with
cisplatin.
Introduction
full-length
into
HFK+HPV16
resulted
attenuation
cellular
growth
(in
hTERT
HFK,
promoted
enhanced
proliferation).
An
understudied
interaction
between
E2
investigated
whether
this
was
important
viral
life
cycle.
We
generated
mutant
genomes
interact
resulting
profound
phenotypes
primary
HFK.
induced
hyper-proliferation,
but
an
ultimate
arrest
growth;
β-galactosidase
staining
demonstrated
senescence,
COMET
assays
showed
DNA
damage
compared
wild
cells.
There
failure
cycle
organotypic
rafts
HFK
premature
differentiation
reduced
proliferation.
results
indicate
E2-p53
critical
during
cycle,
disruption
has
anti-viral
potential.
discuss
potential
mechanisms
explain
these
phenotypes.
Importance
around
5%
all
currently
no
antivirals
available
combat
infections
therefore
it
remains
a
priority
enhance
our
understanding
HPV
replication/transcription/segregation
factor
tumor
suppressor
p53,
role
demonstrates
why
case.
If
disrupted
then
fail
proliferate,
have
there
Results
suggest
targeting
would
therapeutic
benefits,
potentially
attenuating
spread
HPV16.
Oncogene,
Journal Year:
2024,
Volume and Issue:
43(28), P. 2184 - 2198
Published: May 24, 2024
Abstract
Human
papillomaviruses
(HPV)
are
a
major
cause
of
malignancy,
contributing
to
~5%
all
human
cancers
worldwide,
including
most
cervical
cancer
cases
and
growing
number
anogenital
oral
cancers.
The
HPV
viral
oncogenes,
E6
E7,
manipulate
many
host
cellular
pathways
that
promote
cell
proliferation
survival,
predisposing
infected
cells
malignant
transformation.
Despite
the
availability
highly
effective
vaccines,
there
still
no
specific
anti-viral
therapies
targeting
or
treatments
for
HPV-associated
As
such,
better
understanding
viral-host
interactions
may
allow
identification
novel
therapeutic
targets.
Here,
we
demonstrate
actin-binding
protein
LASP1
is
upregulated
in
significantly
correlates
with
poorer
overall
survival.
In
positive
cancer,
depletion
inhibited
oncogenic
phenotype
vitro,
whilst
having
minimal
effects
negative
cells.
Furthermore,
SH3
domain
essential
LASP1-mediated
oncogenicity
these
Mechanistically,
show
E7
regulates
at
post-transcriptional
level
by
repressing
expression
miR-203,
which
negatively
mRNA
levels
binding
its
3’UTR.
Finally,
required
growth
an
vivo
tumourigenicity
model.
Together,
data
induces
survival
thus
identifying
potential
target
Journal of Virology,
Journal Year:
2024,
Volume and Issue:
98(9)
Published: Aug. 28, 2024
We
have
demonstrated
that
SAMHD1
(sterile
alpha
motif
and
histidine-aspartic
domain
HD-containing
protein
1)
is
a
restriction
factor
for
the
human
papillomavirus
16
(HPV16)
life
cycle.
Here,
we
demonstrate
in
HPV-negative
cervical
cancer
C33a
cells
foreskin
keratinocytes
immortalized
by
HPV16
(HFK+HPV16),
recruited
to
E1-E2
replicating
DNA.
Homologous
recombination
(HR)
factors
are
required
replication,
viral
replication
promotes
phosphorylation
of
SAMHD1,
which
converts
it
from
dNTPase
an
HR
independent
E6/E7
expression.
A
phospho-mimic
(SAMHD1
T592D)
reduces
E1-E2-mediated
DNA
has
enhanced
recruitment
In
HFK+HPV16
cells,
T592D
attenuates
cellular
growth,
but
does
not
attenuate
growth
isogenic
HFK
alone.
also
development
foci
following
keratinocyte
differentiation.
The
results
indicated
could
be
therapeutically
beneficial
with
genomes.
Protein
phosphatase
2A
(PP2A)
can
dephosphorylate
PP2A
function
inhibited
endothall.
endothall
DNA,
mimicking
phenotypes.
Finally,
head
neck
cell
lines
episomal
genomes,
their
genome.
suggest
targeting
phosphatases
therapeutic
potential
treatment
HPV
infections
cancers.
Frontiers in Cell and Developmental Biology,
Journal Year:
2022,
Volume and Issue:
10
Published: Oct. 19, 2022
The
characteristic
feature
of
a
cancer
microenvironment
is
the
presence
highly
elevated
concentration
L-lactate
in
tumor
niche.
lactate-rich
environment
also
maintained
by
commensal
mucosal
microbiota,
which
has
immense
potential
for
affecting
cells
through
its
receptoric
and
epigenetic
modes
action.
Some
these
lactate
activities
might
be
associated
with
failure
anticancer
therapy
as
consequence
drug
resistance
acquired
cells.
Upregulation
cellular
DNA
repair
capacity
enhanced
efflux
are
most
important
mechanisms
that
account
ineffective
radiotherapy
drug-based
therapies.
Here,
we
present
recent
scientific
knowledge
on
role
HCA1
receptor
intrinsic
activity
an
HDAC
inhibitor
development
therapy-resistant
phenotype,
special
focus
cervical
In
addition,
study
highlighted
viable
interactions
between
mammalian
microorganisms
female
reproductive
tract
demonstrated
interesting
mechanism
regulating
efficacy
retroviral
transduction
lactate-driven
modulation
DNA-PKcs
localization.
To
date,
very
few
studies
have
focused
enhancement
upregulation
particular
multidrug-resistance
proteins
respect
to
their
intracellular
regulatory
triggered
lactate.
This
review
presents
main
achievements
field
impact
cell
biology
may
promote
undesirable
alterations
physiology
mitigate
infections.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 15, 2023
We
have
demonstrated
that
SAMHD1
(sterile
alpha
motif
and
histidine-aspartic
domain
HD-containing
protein
1)
is
a
restriction
factor
for
the
HPV16
life
cycle.
Here
we
demonstrate
in
HPV
negative
cervical
cancer
C33a
cells
human
foreskin
keratinocytes
immortalized
by
(HFK+HPV16),
recruited
to
E1-E2
replicating
DNA.
Homologous
recombination
(HR)
factors
are
required
replication
viral
promotes
phosphorylation
of
SAMHD1,
which
converts
it
from
dNTPase
an
HR
independent
E6/E7
expression.
A
phosphor-mimic
(SAMHD1
T592D)
reduces
mediated
DNA
has
enhanced
recruitment
In
HFK+HPV16
T592D
attenuates
cellular
growth,
but
does
not
attenuate
growth
isogenic
HFK
alone.
also
development
foci
following
keratinocyte
differentiation.
The
results
indicated
could
be
therapeutically
beneficial
with
genomes.
Protein
phosphatase
2A
(PP2A)
can
dephosphorylate
PP2A
function
inhibited
endothall.
endothall
DNA,
mimicking
phenotypes.
Finally,
head
neck
cell
lines
episomal
genomes
their
genome.
suggest
targeting
phosphatases
therapeutic
potential
treatment
infections
cancers.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 8, 2024
Human
papillomaviruses
(HPV)
are
a
major
cause
of
malignancy,
contributing
to
~5%
all
human
cancers
worldwide,
including
most
cervical
cancer
cases
and
growing
number
ano-genital
oral
cancers.
The
HPV
viral
oncogenes,
E6
E7,
manipulate
many
host
cellular
pathways
that
promote
cell
proliferation
survival,
predisposing
infected
cells
malignant
transformation.
Despite
the
availability
highly
effective
vaccines,
there
still
no
specific
anti-viral
therapies
targeting
or
treatments
for
HPV-associated
As
such,
better
understanding
viral-host
interactions
may
allow
identification
novel
therapeutic
targets.
Here,
we
demonstrate
actin-binding
protein
LASP1
is
upregulated
in
significantly
correlates
with
poorer
overall
survival.
In
positive
cancer,
depletion
inhibited
vitro,
whilst
having
minimal
effects
negative
cells.
Furthermore,
show
SH3
domain
essential
LASP1-mediated
these
Mechanistically,
E7
regulates
at
post-transcriptional
level
by
repressing
expression
miR-203,
which
negatively
regulated
mRNA
levels
binding
its
3'UTR.
Finally,
demonstrated
required
growth
an
vivo
tumourigenicity
model.
Together,
data
induces
survival
role
thus
identifying
potential
target
PubMed,
Journal Year:
2023,
Volume and Issue:
25(10), P. 665 - 673
Published: Oct. 9, 2023
Recessive
dystrophic
epidermolysis
bullosa
(RDEB)
is
a
genetic
skin
fragility
and
ultimately
lethal
blistering
disease
caused
by
mutations
in
the
COL7A1
gene
which
responsible
for
coding
type
VII
collagen.
Investigating
pathological
mechanisms
novel
candidate
therapies
RDEB
could
be
fostered
new
cellular
models.
The
aim
of
this
study
was
to
employ
CRISPR/Cas9
technology
development
immortalized
COL7A1-deficient
keratinocyte
cell
lines
intended
application
as
model
ex
vivo
studies.In
experimental
study,
we
used
transient
transfection
express
-targeting
guide
RNA
(gRNA)
Cas9
HEK001
line
followed
enrichment
with
fluorescent-activated
sorting
(FACS)
via
GFP
expressing
cells
(GFP+
HEK001).
Homogenous
single-cell
clones
were
then
isolated,
genotyped,
evaluated
collagen
expression.
We
performed
scratch
assay
confirm
functional
effect
knockout.We
achieved
46.1%
(P<0.001)
efficiency
in/del
induction
enriched
transfected
population.
Except
4%
single
nucleotide
insertions,
remaining
in/dels
deletions
different
sizes.
Out
nine
expanded
clones,
two
homozygous
heterozygous
obtained
defined
mutation
sequences.
No
off-target
detected
knockout
lines.
Immunostaining
western
blot
analysis
showed
lack
(COL7A1)
protein
expression
these
also
that
had
higher
motility
compared
their
wild-type
counterparts.We
reported
first
isogenic
provide
useful
culture
investigate
aspects
biology
potential
therapeutic
options.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2021,
Volume and Issue:
unknown
Published: Nov. 2, 2021
Abstract
Human
papillomaviruses
(HPV)
are
causative
agents
in
ano-genital
and
oral
cancers;
HPV16
is
the
most
prevalent
type
detected
human
cancers.
The
E6
protein
targets
p53
for
proteasomal
degradation
to
facilitate
proliferation
of
infected
cell.
However,
immortalized
cells
predominantly
spliced
(E6*)
unable
degrade
p53.
Here
we
demonstrate
that
foreskin
keratinocytes
by
(HFK+HPV16),
positive
oropharyngeal
cancers,
retain
significant
expression
In
addition,
levels
can
be
increased
HPV16+
head
neck
cancer
cell
lines
following
treatment
with
cisplatin.
Introduction
full-length
into
HFK+HPV16
resulted
attenuation
cellular
growth
(in
hTERT
HFK,
promoted
enhanced
proliferation).
An
understudied
interaction
between
E2
investigated
whether
this
was
important
viral
life
cycle.
We
generated
mutant
genomes
interact
resulting
profound
phenotypes
primary
HFK.
induced
hyper-proliferation,
but
an
ultimate
arrest
growth;
β-galactosidase
staining
demonstrated
senescence,
COMET
assays
showed
DNA
damage
compared
wild
cells.
There
failure
cycle
organotypic
rafts
HFK
premature
differentiation
reduced
proliferation.
results
indicate
E2-p53
critical
during
cycle,
disruption
has
anti-viral
potential.
discuss
potential
mechanisms
explain
these
phenotypes.
Importance
around
5%
all
currently
no
antivirals
available
combat
infections
therefore
it
remains
a
priority
enhance
our
understanding
HPV
replication/transcription/segregation
factor
tumor
suppressor
p53,
role
demonstrates
why
case.
If
disrupted
then
fail
proliferate,
have
there
Results
suggest
targeting
would
therapeutic
benefits,
potentially
attenuating
spread
HPV16.